The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | Dave Fornell, Editor

Here is a list of the key late-breaking clinical study presentations at the 2019 American Heart Association (AHA) annual meeting, Nov. 16-18, 2019, in Philadelphia.

Home November 19, 2019
Home
News | Pacemakers

(February 2020 update โ€” the results of this trial led to the FDA clearnace of the Micra AV device in January 2020 - FDA ...

Home November 15, 2019
Home
News | Deep Vein Thrombosis (DVT)

November 7, 2019 โ€” The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 7, 2019 โ€” Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 14, 2019 โ€” There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

Home November 14, 2019
Home
News | AHA

November 14, 2019 โ€” More than a million Americans face a doubling in their risk of death during or while recovering from ...

Home November 14, 2019
Home
News | AHA

November 14, 2019 โ€” A new study from researchers at the Smidt Heart Institute at Cedars-Sinai shows that electronic ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 14, 2019 โ€” Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

Home November 14, 2019
Home
News | AHA

November 14, 2019 โ€” A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the NCDR ...

Home November 14, 2019
Home
News | Drug-Eluting Balloons

November 7, 2019 โ€” The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...

Home November 14, 2019
Home
Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019
Feature | VIVA

November 14, 2019 โ€” The results of the 21 late-breaking clinical trials presented for the first time at Vascular ...

Home November 14, 2019
Home
News | Cardiovascular Ultrasound

November 14, 2019 โ€” Ultromics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Home November 14, 2019
Home
News | Pacemakers

https://www.dicardiology.com/channel/pacemakersTexas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the National Institutes of Health (NIH) to explore further the development of a novel pacemaker system that is both leadless and wirelessly powered.

Home November 13, 2019
Home
News | Atherectomy Devices

November 7, 2019 โ€” The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

Home November 11, 2019
Home
Subscribe Now